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 ABSTRACT 
 
Mechanisms of Tungsten Carbide-Cobalt  
 
Nanoparticle- induced Angiogenesis 
 
Yingxue Zhu 
     
Hard metal or cemented carbide consists of a powder mixture of 80 to 90% of 
tungsten carbide (WC) and 5 to 10% of metallic cobalt (Co). Nanoparticles are 
engineered structures with one dimension of at least 100 nanometers or smaller. The 
small size results in properties that may be substantially different from particles of the 
same composition in the micrometer scale. It has been demonstrated that the inhalation of 
hard metal particles may cause an interstitial pulmonary disease and lung cancer, the 
mechanism of which involves an interaction between Co and WC particles, the 
generation of reactive oxygen species, and oxidant-induced DNA-damage (1,2,3,4).  
However, the effect of WC-Co on biologic responses remains to be elucidated. In this 
study, we analyzed the effects of WC-Co nanoparticles in regulating production of 
reactive oxygen species (ROS), activation of AP-1, NF-κB, VEGF, AKT or ERK, and 
angiogenesis. We also tested the effect of fine- and nano-sizes of WC-Co with equal 
surface area on ROS production and the activation of AKT and ERK. 
Results show that WC-Co nanoparticles at 5 µg/cm2 induce ROS production which 
activates AKT and ERK signaling pathways in lung epithelial cells. ROS also increased 
transcriptional activation of AP-1, NF-κB, as well as VEGF (via AKT and ERK1/2 
activation); while the fine size of WC-Co particles at the same concentration did not have 
significant effect. However, at high concentrations, fine-size WC-Co particles also 
induced ROS production, and AKT and ERK1/2 activation. WC-Co nanoparticles also 
induced angiogenesis in cells. These results identify multiple signaling pathways that are 
activated by WC-Co nanoparticle treatment, and elucidate the potential molecular 
mechanisms of their effects on the cells. This information may be useful for preventing 
potential damage from WC-Co particle exposure in the future. 
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Introduction 
 
Hard metals and nanoparticles:   
The first application of cemented carbide using tungsten carbide-cobalt was in 
the early 1930’s. The main components are tungsten carbide (about 90%) and cobalt 
metal (10%). The development of the mining tools using cemented carbide increased 
the lifespan of rock drills by a factor of at least ten when compared to steel-based 
drilling tools. There has been continuous expansion in the cemented carbide 
application over the last four decades. Currently, cemented carbide hard metals are 
used in a wide range of products from aerospace, automobile, to home appliances. For 
these applications, it is important to have the hard metals with the following 
mechanical properties: hardness, toughness, compressive strength, transverse rupture 
strength, and wear resistance1.The advance in nanotechnology enables us to make 
various types of hard metal particles. Based on different particle size they can be 
categorized into: extra coarse, coarse, medium coarse, medium, fine, submicron, ultra 
fine and nano. There is an increasing interest to use finer and finer cemented carbide 
particles because it is found that hardness and wear resistance increase with 
decreasing the size of hard metals.  The conventional materials have mutually 
exclusive hardness and toughness. Nanotechnology is one of the fastest growing and 
emerging technologies in the US and the world2. Nanoparticles are engineered 
structures with dimension of 100 nanometers or smaller.  The properties of materials 
at this size may substantially differ from the same composition in the micrometer 
scale.  Nanotechnology has a wide-range of applications such as integrated sensors, 
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semiconductors, medical imaging, drug delivery, structural materials, sunscreens, 
cosmetics, and coatings. It is estimated that the global market for 
nanotechnology-related products will reach $15 trillion employing more than 2 
million workers in the USA by 20153. 
It is indicated that the WC-Co nanoparticles have many advantages over the fine 
particles including the greatly improved toughness, hardness and wear resistance.  It 
is estimated that application of WC-Co nanoparticles is emerging and growing to 
replace the WC-Co fine particles in various applications and products for improving 
the mechanical properties of cemented carbide hard metals. Intensive research in 
nanotechnology will lead to an increased risk of exposure to nanoparticles over the 
next years. There is a rising public concern over the adverse health effects of exposure 
to nanoparticles and environmental impact of emerging nanotechnology.  Recent 
evidence indicates that nanoparticles exhibit a higher deposition in all regions of the 
respiratory tract when compared to the fine particles, and the occupational exposure to 
nanoparticles may induce cytotoxicity, pulmonary inflammation, and/or other adverse 
effects in the lung4,5,6. Once deposited in the airways, nanoparticles migrate more 
rapidly to the interstitium, lymph nodes and lung than the fine particles7. 
 
Exposure to nanoparticles and potential toxicity: 
People can get exposed to nanostructures via a variety of sources, such as the 
manufacture of the nanoparticles, the injection with nanoparticles, as well as the usage 
of products containing nanoparticles. It has been demonstrated that the overall 
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behavior of inhaled nanoparticles could be summarized in three steps: (a) 
nanoparticles can enter the body via six principle manners: intra venous, dermal, 
subcutaneous, inhalation, intraperitoneal , and oral8,  (b) afterward, they can be 
absorbed by interaction with biological components (proteins, cells), and distribute to 
various organelles in the body, during which, they may retain the same structure, be 
modified, or be metabolized, (c) finally, they enter the cells and reside in the cells for 
an unknown period of time or until their excretion9.These emerging new materials 
could have several possible modes of toxicity: (a) nanoparticles could have unique 
electronic, optical, and magnetic properties due to their special physical dimensions, 
and it is difficult to predict the toxic effect of the breakdown of nanoparticles10; (b) 
the surface of nanoparticles is involved in a number of catalytic and oxidative 
reactions; if these reactions turn out to be cytotoxic, the toxicity could be greater than 
their bulk material counterpart because of much greater surface area-to-volume ratio, 
(c) nanoparticles  contain metals or compounds with known toxicity, thus their 
breakdown could lead to similar toxic responses as their components11. 
There is concern that environmental or occupational exposures to nanoparticles 
will be a major public health issue12.However, the health and safety regulatory 
structures do not understand yet the extent and potential toxicity of nanoparticles in 
the environment and workplace. The effects of WC-Co nanoparticles and other 
nanoparticles in the cells and animals are not known yet. It has been found that 
WC-Co nanoparticles increased ROS generation, activated several signaling 
molecules, and induced angiogenesis13. Many questions remain to be answered such 
  5 
as the specific type of ROS induced by the nanoparticles, mechanism of ROS 
induction, the connection of ROS production to signaling pathway activation in the 
cells and biological responses such as nanoparticle-induced angiogenesis. 
Many studies demonstrated that tungsten carbide cobalt (hard metal) fine-sized 
and nano-sized particles induce high levels of ROS14,15. 
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ABSTRACT 
 
Studies have shown that the association of tungsten carbide (WC) and metallic 
cobalt (Co) increases reactive oxygen species (ROS) production
1
. Recently, some 
reviews have concluded that the toxic effects of inhaled heavy metal nanoparticles are 
associated with the oxidative stress by the increasing generation of reactive oxygen 
species (ROS)
2
. Based on these reports, we hypothesize that WC-Co nanoparticles 
may also induce ROS in cells. To test whether the hard metal WC-Co nanoparticles 
induce ROS production in lung epithelial cells, we measured the production of ROS 
in cultured BEAS-2B cells treated with WC-Co nanoparticles at different time 
durations. We found that WC-Co nanoparticles strongly induced ROS production in 
BEAS-2B cells. Increase in ROS by nanoparticles was observed 15 minutes after the 
treatment, and reached higher levels 2 hours after the treatment.  
To further determine which species of ROS are generated by the exposure to 
WC-Co nanoparticles, we pretreated cells with the hydrogen peroxide (H202) 
scavenger (catalase). Treatment with catalase inhibited ROS production, suggesting 
that H2O2 is one of the species of ROS generated by nanoparticles. To determine what 
signaling molecules are required for ROS production by WC-Co nanoparticles, we 
specifically tested the involvement of membrane-bound NADPH oxidase, AKT and 
ERK. BEAS-2B and JB6 cell lines (mouse lung epidermal cell lines) were pretreated 
with NADPH-dependent oxidase inhibitor (DPI), PI3K inhibitor (LY294002) and 
MEK inhibitor (U0126), then exposed  to nanoparticles.  Our results show that 
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ROS generation was inhibited by diphenylene  iodonium (DPI) and catalase, but not 
LY294002 and U0126, suggesting that NADPH oxidase is the source of the 
nanoparticle-induced ROS production in both cell lines.  
WC-Co hard metal dust is composed of tungsten carbide (WC) and metallic 
cobalt particles (Co). It has been pointed out that one possible mechanism underlying 
the higher toxicity of WC-Co particles compared with Co or WC alone is the specific 
physicochemical interaction between Co and WC particles, which leads to the 
enhanced short-term formation of ROS
3 ,4
. Thus, we hypothesize that not only 
nano-sized but also fine-sized WC-Co may induce ROS generation in cells. Compared 
to fine-sized WC-Co particles, the nanoparticles have much higher surface area (17.1 
times)
5
. To test whether WC-Co fine-sized particles also induce ROS generation, we 
measured the ROS produced at high concentration of WC-Co fine-sized particles. We 
found that 85.5 µg/cm2 of the fine-sized particles(same surface area of 5 µg/cm2 of 
the nanoparticles) produced only 35% ROS of the nanoparticle treatment with the 
same surface area, which is 75% less than nanoparticle induced ROS generation. 
Our data suggested that 1) the level of ROS production is partially associated 
with the surface area of WC-Co particles and that nanoparticles are more potent in 
inducing ROS in the cells; 2) NADPH oxidase is required for nanoparticle-induced 
ROS production in the cells. 
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INTRODUCTION 
 
 
Reactive oxygen species (ROS) refers to a diverse group of reactive, short-lived 
chemically-reactive molecules which contain oxygen. ROS include superoxide (O2·−), 
hydroxyl radical (·OH), hydrogen peroxide (H2O2) and peroxynitrite(ONOO-)
6
. In 
normal cells, low levels of ROS are produced by all aerobic organisms through the 
oxygen reduction process; they are generated either endogenously from mitochondria, 
metabolic processes, inflammation etc. or from external sources. Increased levels of 
ROS are induced by growth factors and cytokines and are important for cancer cell 
proliferation and tumor development
7
. ROS are produced from a number of sources 
including the mitochondrial electron transport system, xanthine oxidase, cytochrome 
p450, NADPH oxidase, as well as uncoupled NO synthase (NOS) and MPO
8
. Recent 
studies indicated that NADPH oxidases, also known as Nox enzymes, emerged as 
major sources of ROS induction, and may play an important role in ROS generation 
in some cancer cells. Nox enzymes consist of catalytic subunits (Nox1, Nox2, Nox4, 
Nox5) and cytosolic regulatory subunits (p47phox, p67phox, the small GTPase 
Rac1)
9 , 10
. Cells have developed a variety of enzymatic and non-enzymatic 
mechanisms to defend themselves against damage resulting from oxidative stress, 
including antioxidant defenses through glutathione and antioxidant enzymes. The 
most important antioxidant enzymes include the superoxide dismutases (SOD
-1
 and 
SOD
-2
), which catalyze O2·
− 
to H2O2 and H2O; catalase, which catalyzes H2O2 to O2 
and H2O; and glutathione peroxidase which converts H2O2 to H2O
11,12,13
. Tumor cells 
show elevated ROS content compared to normal cells in numerous current reports; 
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moreover, the endogenous ROS are reported to be important in controlling tumor cell 
growth. In fact, emerging evidence has shown that reactive oxygen species (ROS) 
contribute to carcinogenesis and the malignant progression of  tumor cells  in 
different ways: they act as cell signaling intermediates to drive genomic damage and 
genetic instability, promote cell motility, shape the tumor microenvironment by 
inducing inflammation and inducing angiogenesis. It has been suggested recently that 
the adverse and toxic effects of inhaled nanoparticles may be associated with the 
oxidative stress induced by the increasing generation of ROS. Thus, we will 
investigate which types of ROS are formed by the exposure to WC-Co; what 
signaling pathways are involved in ROS generation; we will specifically test the 
involvement of membrane-bound NADPH, and the role of PI3K and ERK1/2 in ROS 
production, furthermore, we will study the effect of fine-sized particle in ROS 
production. 
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Materials and methods 
Chemical Reagents 
Catalase was purchased from SIGMA-ALDRICH( St Louis), U0126, LY294002 
and diphenylene iodonium (DPI) were obtained from Calbiochem (La Jolla, CA). 
Dulbecco's Modified Eagle Medium (DMEM) was purchased from 
Mediatech,Inc(Manassas,VA.).  Eagle's minimal essential medium (MEM) and 
phosphate-buffered saline (PBS) were purchased from Whittaker Biosciences 
(Walkersville, MD). Fetal bovine serum (FBS), gentamicin and l-glutamine were 
from Life Technologies, Inc. (Gaithersburg MD). 2′,7′-dichlorofluorescein diacetate 
(DCDF-DA) and dihydroethidium were obtained from Molecular Probes (Eugene, 
OR). 
 
Cell culture 
The human bronchial endothelial cell line BEAS-2B was grown in DMEM 
 
supplemented with 10% heat inactivated fetal bovine serum, 2 mM L-glutamine, 0.2% 
insulin,
 
100 U/ml penicillin, and 100 µg/ml streptomycin, and cultured
 
at 37°C in 
humidified 5% CO2 incubator.  The mouse lung epidermal cell line JB6 was cultured 
in Eagle's MEM, containing 5% heat inactivated fetal bovine serum, 2 mM 
L-glutamine, and 50 µg of gentamicin/ml. 
 
 WC-Co Particles preparation 
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Nano-sized WC–Co, with average particle size 80 nm, were obtained from 
Inframat Advanced Materials, Farmington, CT. (Purity of the nanoparticles was 
99.9%).  These nanoparticles were WC and Co molecularly mixed, with 15% of Co, 
fine WC–Co particles, with average size 4 µm  were WC and Co molecularly mixed, 
with 6% of Co were purchased from Alfa AESAR (A Johnson Mattey Company, 
Ward Hill, MA), with purity of the fine particles at 99.9%. The suspensions of nano- 
or fine-sized WC–Co were prepared by sonication with PBS to disperse the particles 
using a Branson Sonifier 450 (Danbury, CT) for 2–3 min prior to exposure. 
 
Intracellular hydrogen peroxide (H2O2) detection 
BEAS-2B cells were seeded on coverslips in a 6-well plate, and cultured 
overnight.  Cells were maintained in the presence or absence of 5 µg/cm2 fine- or 
nano-sized WC-Co for the indicated time period, followed by incubation with 5 µM  
2',7'-dichlorofluorescein diacetate (DCFH-DA) for 15 min.  The cells were washed 
twice with phosphate-buffered
 
saline (PBS), and fixed with 10% buffered formalin for 
10 min.  The fluorescent images were captured using a confocal fluorescence 
microscope.  In order to test the effects of catalase, LY294002, or U0126, cells were 
pre-treated with these reagents for 30 min, particles were added and cells were 
subsequently treated as above.   
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RESULTS 
 
WC-Co nanoparticles induced ROS production in BEAS-2B cells 
To measure the production of ROS in cultured BEAS-2B cells treated with 
WC-Co nanoparticles, the cells were seeded on the cover-slip the night before the 
treatment, then treated either with solvent, the fine-sized or nano-sized particles. The 
results indicate that the nano-size particles induced high levels of ROS production in 
the cells; this was not observed in the control and the fine-size particle group (Fig. 1). 
The effect of the nanoparticles in inducing ROS production was observed as early as 
15 min after the treatment, and reached highest levels at 2 hours after the treatment 
(Fig. 2). These data demonstrate that WC-Co nanoparticles strongly induce ROS 
production in BEAS-2B cells.   
 
The ROS production was inhibited by diphenylene iodonium (DPI) and catalase 
The Beas-2B cells were cultured as described above.  The cells were pretreated 
with DPI (NADPH oxidase inhibitor) and catalase, the hydrogen peroxide (H202) 
scavenger; followed by treatment with nanoparticles. The ROS production was 
inhibited by DPI and catalase treatment (Fig. 3.A).  PI3K inhibitor LY294002 and 
MEK inhibitor U0126 did not inhibit the ROS generation (Fig. 3.B).  This result 
suggested that NADPH oxidase is required for the nanoparticle-induced ROS 
production in the cells.   
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WC-Co nanoparticles induced ROS production in JB6 cells; ROS production was 
inhibited by catalase and DPI 
The JB6 cells were cultured on the cover-slip, and treated with solvent, the 
fine-sized or nano-sized particles in the absence or presence of catalase or DPI as 
described in Fig. 4.  The nanoparticles, but not the fine particles, induced ROS 
production in JB6 cells. The induction of ROS could be inhibited by the addition of 
catalase or DPI (Fig. 4).  These results demonstrate that nanoparticles have similar 
effects in two different cell lines with respect to inducing ROS generation.  
 
High concentrations of WC-Co fine particles also induced ROS production in 
BEAS-2B cells   
The nanoparticles have much higher surface area –around 17.1 times higher than 
fine particles.  To test whether high concentrations of WC-Co fine particles may also 
induce ROS production, BEAS-2B cells were treated with 28.5, 57, or 85.5 µg/cm2 of 
the fine particles for 30 min.  The cells treated with the solvent or 5 µg/cm2 WC-Co 
nanoparticles were used as the negative and positive controls, respectively.  The 
results indicated that the increasing amount of fine particles induced higher levels of 
ROS production in the cells, and 85.5 µg/cm2 of the fine particles, which has the 
same surface area as 5 µg/cm2 of the nanoparticles, produced 35% ROS levels of the 
nanoparticle treatment (Fig. 5).  This result demonstrates that 1) ROS production is 
partially associated with the surface area of WC-Co particles; 2) the nanoparticles are 
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more potent in inducing the ROS; and 3) high concentrations of WC-Co fine particles 
can also induce the ROS production.   
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Figures and Legends 
 
Fig.1. WC-Co nanoparticles induce ROS production 
 
 
 
 
 
            
 
 
 
 
 
 
Fig.1. WC-Co nanoparticles induce ROS production.  BEAS-2B cells were plated on a glass 
slip in the 6-well plate, and incubated at 37°C for 24 h.  The cells were then cultured in 
serum-free medium with fine-size or nano-size WC-Co particles at 5 µg/cm2 for 30 min.  
DCFH-DA (5 µM) was added and incubated with the cells for 15 min.  Then, the cells were 
washed and fixed.  The images were captured with a fluorescence microscope.  The 
fluorescent images were captured using a confocal microscope (upper panel).  The 
corresponding phase micrographs are shown in the bottom panel.  Bar: 200 µm.   
 
Fig.2. Effects of WC-Co nanoparticles at 5 µg/cm2 on ROS production at different 
time-points.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2. Effects of WC-Co nanoparticles at 5 µg/cm2 on ROS production at different 
time-points.  BEAS-2B cells were plated on a glass slip in the 6-well plate, and incubated at 
37°C for 24 h. The cells were then cultured in serum-free medium in the presence of 
nanoparticles at 5 µg/cm2 for time periods as indicated.  DCFH-DA (5 µM) was added and 
incubated with the cells for 15 min.  Then the cells were washed and fixed, and the images 
were captured as above.  The fluorescent images were captured using a confocal 
Control          Fine            Nano 
 
    0 min          15 min        30 min         1 h           2 h 
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microscope (upper panel).  The corresponding phase micrographs are shown in the bottom 
panel.  Bar: 200 µm.   
 
Fig.3. Catalase and DPI treatment inhibited ROS production induced by the 
nanoparticles.   
 
 
 
 
 
 
 
 
 
                                                                                                          
 
 
 
 
 
Fig.3. Catalase and DPI treatment inhibited ROS production induced by the nanoparticles.  
BEAS-2B cells were plated on a glass coverslip in the 6-well plate, and incubated at 37°C for 
24 h.  The cells were then cultured in serum-free medium without or with 2000 U/ml catalase 
or 5µM DPI (A); 10 µM LY294002 or 10µM U0126 (B) for 1 h.  Then cells were treated with 5 
µg/cm2 WC-Co nanoparticles for 30 min.  DCFH-DA was added to the cells, and fluorescent 
images were obtained as above.  A, Catalase and DPI inhibited ROS production.  B, 
LY294002 and U0126 did not have effect on ROS production. 
                          
 
Fig.4. The induction of ROS was inhibited by the addition of catalase and DPI in JB6 
cell lines 
 
 
 
                          
 
 
 
 
 
 
 
 
 
 
  Control           Catalase           DPI 
A 
    Control           LY             U0126 
B 
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Fig.4. JB6 cells were plated onto a glass slip in the 6-well plate, and incubated at 37°C for 24 h.  
Some cells were pretreated with 2000 U/ml catalase or 5 µM DPI in medium containing 0.1% 
FBS for 1 h.  Then cells were incubated without or with fine-size or nano-size WC-Co 
particles at 5 µg/cm2 for 30 min.  DCFH-DA (5 µM) was added and incubated with the cells 
for 15 min.  Then the cells were washed and fixed.  The images were captured with a 
fluorescent microscope.  The fluorescent images were captured using a confocal microscope 
(up panel).  The corresponding phase micrographs were shown in the bottom panel.  Bar: 
200 µm.   
 
Fig.5. High concentrations of WC-Co fine particles also induced ROS production 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.5. High concentrations of WC-Co fine particles also induced ROS production.  BEAS-2B 
cells were plated on a glass slip in the 6-well plate, and incubated at 37°C for 24 h.  The cells 
were then cultured in serum-free medium with fine-size WC-Co particles at 28.5, 57, or 85.5 
µg/cm2 for 30 min. The cells treated with solvent (control) or 5 µg/cm2 nanoparticles were used 
as negative or positive control.   DCFH-DA (5 µM) was added and incubated with the cells for 
15 min.  The cells were washed and fixed.  The ROS signals were captured with a 
fluorescence microscope (Fig. 6A).  The corresponding phase micrographs were shown on 
the bottom panel.  Bar: 200 µm.  The ROS signals were quantified using a confocal 
microscope from 6 replicate slides (Fig. 6B).   
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DISCUSSION 
 
 
Several studies have demonstrated that ROS production by heavy metal WC-Co 
appears to be dependent on the physical and chemical properties of the particles, such 
as particle size, dissolution behavior, surface reactivity and binding ability
14
. In this 
study, we found that although fine-sized particles also induce ROS production, it is 
75% less than nanoparticles with the same surface area; this may be due to the greater 
surface area-to-volume ratio of nanoscale material, and it also suggests that particle 
size of WC-Co has significant effect on ROS production.  
We further found that the induction of ROS by nanoparticles increased with 
time, and reached the highest level after 2 hours of nanoparticle treatment, however, it 
is interesting to investigate ROS level at longer time points to get a general idea of the 
pattern of time-dependent ROS induction. To study the biological mechanism how 
nano-sized or fine- sized WC-Co particles increase ROS production, we co-treated 
cells with NADPH-dependent oxidase inhibitor DPI, the hydrogen peroxide (H202) 
scavenger catalase, PI3K inhibitor LY294002, MEK inhibitor U0126 and 
nanoparticles.  Results show that ROS production was inhibited by DPI and catalase, 
but not U0126 and LY294002, which suggests that hydrogen peroxide (H202) is one 
of the ROS types generated by nanoparticles via NADPH oxidase activity, but not via 
AKT and ERK.   
Although PI3K inhibitor and MEK inhibitor did not influence ROS production, 
these two pathways may act as the downstream signaling mediators of ROS. We 
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found the WC-Co nanoparticles induced ROS generation in both BEAS-2B cells and 
JB6 cells, this suggested that fine or ultra fine particles of WC-Co induced ROS 
generation in two different cell types.         
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CHAPTER III 
 
 
 
 
 
 
 
 
 
WC-Co nanoparticles activate AKT and ERK1/2 through ROS generation 
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ABSTRACT 
 
We found in our preliminary studies that ROS generation induced by WC-Co 
nanoparticles was inhibited by DPI, but not U0126 and LY294002, indicating that 
NADPH oxidase, but not PI3K/AKT and MEK/ERK pathways, are required for 
nanoparticle-induced ROS production. However, we hypothesized that ROS may act 
as the upstream regulator of AKT and ERK1/2, to test this hypothesis, we first 
determined whether WC-Co nanoparticles affect AKT and extracellular 
signal-regulated kinase (ERK) activation. BEAS-2B cells were treated with the 
nano-size or fine-size WC-Co particles, and activation of AKT and ERK1/2 was 
analyzed by Western blotting.  The nanoparticles were found to induce AKT and 
ERK1/2 activation at the low concentration of 2.5 µg/cm2 which increased with 
higher doses, while fine particles of WC-Co had only modest effect even at high 
concentrations(50 µg/cm2). Further, we wanted to determine whether ROS may be 
the upstream regulator of AKT and ERK. The cells treated as above were analyzed for 
the activation of AKT and ERK by immunoblotting.  Treatment with catalase 
inhibited levels of both phospho-AKT and phospho-ERK.  As a control, LY294002 
and U0126 decreased WC-Co nanoparticle-induced AKT and ERK activation, 
respectively. These results indicate that WC-Co nanoparticles regulate AKT and ERK 
pathways through ROS production.   
High concentration of WC-Co fine particles can also induce ROS generation (as 
indicated in chapter 1), thus, it is tempting to test whether high concentrations of 
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WC-Co fine particles can also induce AKT and ERK1/2 activation. Our results show 
that 57µg/cm2 and 85.5µg/cm2 fine-sized WC-Co particles induced AKT and 
ERK1/2 activation in cells, and that increasing concentrations of WC-Co fine particles 
were associated with higher levels of AKT and ERK1/2 activation. However, the 
levels of AKT and ERK1/2 activation induced by 85.5 µg/cm2 fine-sized WC-Co 
particles were not as high as those achieved by 5 µg/cm2 WC-Co nanoparticles, 
suggesting that the WC-Co fine-sized particles at high concentrations are also able to 
induce AKT and ERK1/2 activation, but not as strongly as nano-sized particles.  This 
is consistent with their effect on ROS generation in cells compared to nano-sized 
particles.  
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INTRODUCTION 
 
The mitogen-activated protein kinases (MAPK) are a large family of 
serine/threonine kinases that require tyrosine and threonine phosphorylation for 
activation through MAPK cascades, which involve a core of three protein kinases: 
MAP kinase kinase kinase(MAPKKK), MAP Kinase Kinase(MAPKK) and MAP 
Kinase(MAPK)
1,2
. Based on different motifs in the activation loop, MAPKs are 
classified into: extracellular signal regulated kinases (ERKs), c-jun N-terminal kinases 
(JNKs) and p38 MAPKs. The ERKs mainly regulate proliferation and differentiation, 
while the JNKs and p38MAP kinases are associated with responses to cellular 
stresses
3,4
. ERK1/2 are part of a mitogen-activated protein kinase (MAPK) cascade 
consisting of sequentially functioning kinases—Raf, MEK (MAPKK) and ERK1/2 
(MAPK)
5
. Active ERK1/2 induce reprogramming of gene expression by 
phosphorylating various intracellular target proteins and transcription factors and 
thereby initiate cell growth, proliferation, differentiation and anti-apoptotic effects
6
. 
Recently,  rapidly growing evidence suggested that increased ROS levels can also 
activate MEK/ERK pathway
7
. 
The phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that 
propagate signaling cascades to regulate a wide range of cellular processes, such as 
proliferation and apoptosis
8
. PI3K phosphorylates the 3′-OH group of 
phosphatidylinositols at the plasma membrane, leading to the recruitment of the 
protein Ser/Thr-kinase, AKT, to the cell membrane, thus activating AKT. The 
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PI3K/AKT signaling cascade is demonstrated to play a crucial role in carcinogenesis 
as it promotes cell survival and growth
9,10
. PI3K–AKT signaling is activated in cancer 
by several different mechanisms. 
In recent years, a growing body of literature points toward the importance of 
ROS in mediating cell proliferation. They act as second messengers to modulate the 
activation of several signaling pathways
11
. A number of reports showed that the 
PI3K/Akt cascade is activated by ROS
12
. PI3K/AKT and MEK/ERK pathways play a 
vital role in regulating multiple cellular functions. Consequently, in this chapter, we 
will use AKT inhibitor LY294002 and ERK1/2 inhibitor U0126 to specifically test the 
involvement of MEK/ERK and PI3K/AKT pathways in ROS production via 
nano-scale particles or high concentration of fine particles.  
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MATERIALS AND METHODS 
 
Reagents 
The antibodies against ERK, phospho-ERK(Thr202/Tyr204)/phospho-p44/p42 
MAPK(Thr202/Tyr204), phospho-AKT (Ser473), AKT and ERK2 were from Cell 
Signaling Technology (Beverly, MA) 
 
Western blotting 
The cells were lysed in Radio Immuno Precipitation Assay(RIPA) buffer [150 
mM NaCl, 100 mM Tris (pH 8.0), 1% Triton X-100, 1% deoxycholic acid, 0.1% SDS, 
5 mM EDTA, and 10 mM NaF], supplemented with Dithiothreitol(DTT) and 
proteinase inhibitors.  The cellular lysates were clarified by centrifugation at 
15,000× g for 10 min. Protein concentrations were determined by the Bradford assay 
(Bio-Rad).   Aliquots of the protein extracts were resolved in SDS/polyacrylamide 
gels and transferred to nitrocellulose membranes.  Membranes were blocked with 
5% nonfat dry milk in 1x PBS buffer containing 0.05% Tween 20, and incubated with 
primary antibodies against phospho-AKT, AKT, phospho-ERK1/2 (Cell Signaling 
Technology, Beverly, MA), and ERK2 (Santa Cruz Biotechnology, Santa Cruz, CA).  
Bands were detected by incubating the membrane with horseradish 
peroxidase-conjugated secondary antibodies and visualized with a chemiluminescence 
reagent (Pierce Biotechnology, Rockford, IL). Then indicated membranes were 
stripped in a stripping buffer (50mM glycine, 100mM KCl, 0.5mM EDTA, 
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2-mercoptomethanol, 7M guandine hydrochloride) for 15 min at room temperature 
and washed three times with wash buffer for 15 min each time before reusing.   
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RESULTS 
 
 
WC-Co nanoparticles induced AKT and ERK1/2 activation 
BEAS-2B cells were cultured in serum-free medium overnight, then treated with 
nano-size WC-Co particles at different doses for 30 min.  We found that low doses 
of WC-Co nanoparticles from 2.5 to 20 µg/cm2 resulted in an increasing of 
phosphoAKT and phosphoERK1/2, indicating activation (Fig. 1 and 2).  In contrast, 
the expression of total AKT and ERK1/2 did not change. 
 
WC-Co nanoparticles activated AKT and ERK pathways through ROS generation 
To test whether ROS may be the upstream regulator of AKT and ERK, the cells 
were treated as above and analyzed for the activation of AKT and ERK by 
immunoblotting.  The treatment with catalase inhibited levels of both phospho-AKT 
and phospho-ERK in the cells (Fig. 3).  As a control, LY294002 and U0126 
decreased WC-Co nanoparticle-inducing AKT and ERK activation, respectively. 
These results indicate that WC-Co nanoparticles regulate AKT and ERK pathways 
through ROS production.   
 
High concentrations of WC-Co fine particles also induced AKT and ERK1/2 
activation 
To study whether high concentrations of the fine particles induced AKT and 
ERK1/2 activation, BEAS-2B cells were cultured in serum-free medium overnight, 
followed by treatment with 28.5, 57, and 85.5 µg/cm2 fine-size WC-Co particles for 
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30 min.  The cells were used to analyze AKT and ERK1/2 activation by 
immunoblotting.  The increasing concentrations of WC-Co fine particles were 
associated with higher levels of AKT activation (Fig. 4.A).  Similarly, 57 and 85.5 
µg/cm2 fine-size WC-Co particles induced ERK1/2 activation in the cells (Fig. 4.B).  
The levels of AKT and ERK1/2 activation induced by 85.5 µg/cm2 fine-size WC-Co 
particles were not as high as those treated with 5 µg/cm2 WC-Co nanoparticles, 
suggesting that 1) the WC-Co fine-size particles at high concentrations are able to 
induce AKT and ERK1/2 activation; and 2) the nanoparticles are more potent in 
inducing AKT and ERK1/2 activation in the cells.   
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Figures and Legends 
 
 
Fig.1. Effects of nanoparticles on phospho-AKT expression in vitro 
 
 
 
 
 
 
 
 
 
Fig.1. Effects of nanoparticles on phospho-AKT expression in vitro.  Beas-2B cells were 
cultured in serum-free medium for 20 h, then treated with nano-size and fine-size WC-Co 
particles at different concentrations (0, 2.5, 5, 10, 20, and 50 µg/cm2) for 30 min.  The cells 
were collected, and total proteins were subjected to immunoblotting analysis with antibodies 
against p-AKT and total AKT. 
 
 
Fig.2. Effects of nanoparticles on phospho-ERK1/2 (ERK) expression in vitro  
 
 
 
 
 
                                                                                                                        
  
 
  
 
Fig.2. Effects of nanoparticles on phospho-ERK1/2 (ERK) expression in vitro.  Beas-2B cells 
were cultured in serum-free medium for 20 h, then treated with nano-size or fine sized WC-Co 
particles at different concentrations (0, 2.5, 5, 10, 20, and 50 µg/cm2) for 30 min.  Then cells 
were collected, and the total proteins were subjected to immunoblotting analysis with 
antibodies against p-ERK1/2 and total ERK1/2.  
 
 
Fig.3. effect of catalase, LY294002 and U0126 and nanoparticles on AKT and ERK1/2 (ERK) 
activation.   
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Fig.3. effect of catalase, LY294002, U0126 and nanoparticles on AKT and ERK1/2 activation. 
BEAS-2B cells were cultured to 80% confluence, then treated with 3000 U/ml of catalase, 20 
µM U0126, or 20 µM LY294002 for 30 min in fresh medium.  Then nano-size of WC-Co at 5 
µg/cm2 was added for 1 h.  Cell lysates were subjected to Western Blotting 
 
 
Fig.4. Effects of high concentration WC-Co fine particles on AKT and ERK1/2 activation.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4. Effects of high concentration WC-Co fine particles on AKT and ERK1/2 (ERK) activation.  
Beas-2B cells were cultured in serum-free medium for 20 h, then treated with nano-size or 
fine-size of WC-Co particles at the indicated concentrations for 30 min.  Cells were lysed and 
the total proteins were subjected to immunoblotting analysis with antibodies against p-AKT 
and total AKT (A) or p-ERK1/2 and total ERK1/2 (B).   
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DISCUSSION 
 
 
We found in the preliminary studies that WC-Co nanoparticles induced ROS 
production in both BEAS-2B and JB6 cells.  ROS generation induced by WC-Co 
nanoparticles was inhibited by catalase and DPI, indicating that NADPH oxidase 
could be source of ROS.  U0126 and LY294002, the inhibitors of PI3K/AKT and 
MEK pathways, did not inhibit ROS production, suggesting that ROS production did 
not require activation of AKT and ERK.  However, WC-Co nanoparticles might 
affect downstream phospho-AKT, phospho-ERK expression. Indeed, our data 
suggested that WC-Co nanoparticles increased the activation of AKT and ERK1/2 
signaling pathways in BEAS-2B cells compared to the same concentration of fine 
sized particles, indicating that PI3K/AKT and MEK/ERK pathways may play 
important roles in WC-Co nanoparticle-mediated functional changes in the cells. 
Because AKT and ERK1/2 signaling pathways were not involved in ROS production, 
we hypothesized that these two pathways may still be activated downstream of ROS. 
In agreement with our predictions, ROS blockade with catalase greatly reduced the 
activation of ERK and AKT.  
It is noteworthy that PI3K/AKT and MEK/ERK pathways are thought to be 
synergistically regulated and crosstalk between them has been reported in some 
cancer cell lines
13,14
. However, in our study, MEK inhibitor U0126 only blocked the 
activation of ERK but had no effect on phospho-AKT, and PI3K inhibitor LY294002 
only inhibits the phosphorylation of AKT but not the phosphorylation of ERK. This 
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suggests that these two pathways are distinct from each other in mediating 
nanoparticle signaling. 
High concentration of fine sized particles induced ROS generation  in this 
study. Moreover, we also found that high concentration of the fine-sized particles 
induced AKT and ERK1/2 activation. Notably, the level of activation is lower than for 
the same area size of nanoparticles, suggesting that: 1) nanoparticles are more potent 
in activating AKT and ERK1/2 pathways in BEAS-2B cells which is consistent with 
their effect on ROS generation, 2) WC-Co as a heavy metal compound induces AKT 
and ERK activation regardless of the physical particle size. 
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WC-Co nanoparticles induced AP-1, NF-κB, and VEGF 
transcriptional activation and angiogenesis 
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ABSTRACT 
 
AP-1, NF-κB, and VEGF are conventionally known to be involved in regulating 
angiogenesis
1,2,3
. This prompted us to hypothesize that elevated levels of ROS caused 
by WC-Co nanoparticle treatment might also upregulate AP-1, NF-κB, and VEGF 
transcriptional activation. Indeed,  BEAS-2B cells treated with 2.5 and 5 µg/cm2 of 
nano-sized WC-CO showed significantly increased AP-1, NF-κB, and VEGF 
transcriptional activation, while fine-sized WC-CO had no effect.  Our results show 
that  nanoparticle treatment results in AP-1, NF-κB, and VEGF transcriptional 
activation.  
Angiogenesis is an essential process during injury repair, inflammatory diseases, 
carcinogenesis, tumor growth and metastasis
4 , 5
. To test the effect of WC-Co 
nanoparticles in angiogenesis, we used chick chorioallantoic membrane (CAM ) assay 
as the in vivo angiogenesis model.  Our results suggest that the nanoparticle 
treatment increased the angiogenic response by more than 5 fold when compared to 
the control group. To further demonstrate the effect of the nanoparticles on 
angiogenesis on a different cell line, human lung adenocarcinoma cells A549 were 
used. We found that treatment of A549 cells with nanoparticles enhanced the 
angiogenic response by 5-fold. These data demonstrate that the WC-Co nanoparticles 
can significantly stimulate different cell lines to induce angiogenesis in vivo. We also 
tested the effects of fine size particles on angiogenesis and found that the fine size 
particles at the same dose did not induce angiogenesis (data not shown).   
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INTRODUCTION 
 
Angiogenesis occurs via the sprouting of new vessels from preexisting blood 
vessels or via the insertion of interstitial tissue columns into the lumen of pre-existing 
vessels (i.e., intussusception)
6
. Tumors cannot grow larger than 1-2 millimeters in 
diameter without an efficient blood supply provided by angiogenesis
7
. Tumor 
angiogenesis can be triggered by extracellular signals, such as growth factors, and by 
genetic alterations, such as activation of oncogenes or deletion of tumor suppressor 
genes. It is a complex process regulated by a balance of angiogenic inducers such as 
VEGF and angiogenic inhibitors such as thrombospondin-1
8
. 
Nuclear factor kappaB (NF-kB), member of the proto-oncogene family rel, is an 
ubiquitous transcription factor. The activated form of NF-kB consists of heterodimer 
p50/p65, it cooperates with other transcription factors to bind to a specific DNA 
sequence, thus induces the expression of various target genes to promote cell 
proliferation and transformation, regulates apoptosis, stimulates invasion and 
metastasis as well as facilitates angiogenesis
9,10
. Activator protein-1 (AP-1) is a 
dimeric protein, which comprises members of the Jun protein family (c-Jun, JunB, 
and JunD) and Fos protein family, consisting either of homodimers between c-Jun, 
JunB, and JunD, or heterodimers with members of the Fos-family via the physical\l 
interaction with "leucine zipper" region
11
. The protein components of AP1 are 
encoded by a set of genes known as "immediate-early" genes that can be activated by 
a variety of growth factors and mitogens through several different signaling 
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pathways
12
. 
Chemical carcinogenesis is a multi-step process involving both mutations and 
deregulated cell proliferation. Oxidative stress can occur through overproduction of 
reactive oxygen species (ROS) or nitrogen species through either endogenous or 
exogenous insults. It has been pointed out by several recent studies that the 
unregulated or prolonged production of cellular oxidants is linked to mutations 
(induced by oxidant-induced DNA damage), as well as the modification of gene 
expression, which is proved to be important in carcinogenesis
13,14
. In particular, signal 
transduction pathways, including transcriptional factors AP-1 and NF-κB, are known 
to be activated by reactive oxygen species, leading to the transcription of genes 
involved in cell growth regulatory pathways
15
. There is already mounting evidence 
that demonstrates the association of ROS generation and carcinogenesis via the 
activation of several key transcription factors such as AP-1 and NF-κB16. 
VEGF is the predominant stimulator of angiogenesis. VEGF secreted by tumor 
cells initiates the angiogenic process by activating endothelial cells and promoting 
their migration, thus, inducing the angiogenic switch
17
. VEGF expression is driven by 
many factors that are characteristic of tumors, including oncogene expression [e.g., 
ras, src, erbB2/human epidermal growth factor receptor 2 (HER2), EGFR] and 
hypoxia]
18
. VEGF also mediates the effects of other angiogenic molecules and 
therefore plays a central role in the control of tumor angiogenesis
19
. Under hypoxic 
conditions, constitutive degradation of HIF-1 α via the proteosome pathway is 
blocked leading to HIF-1 stabilization and activation. HIF-1 is also stabilized through 
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oncogenic signaling, involving src, ras, protein kinase C, and 
phosphatidylinositol-3-OH kinase (PI3K)
20
. In the nucleus, HIF-1 binds the VEGF 
promoter region and  activates transcription of the VEGF gene
21
. 
A number of studies showed that the toxic effect of nanoparticles involves its 
effect on angiogenesis, however, the underlying mechanisms remain unclear
22,23
. 
Based on the vital role played by AP-1, NF-κB and VEGF in angiogenesis, as well as 
their tight relationship with ROS, it is tempting to speculate that AP-1, NF-κB, and 
VEGF transcriptional activation may be involved in the nanoparticle induced 
angiogenesis. Only few studies have focused on in vivo models. Therefore, in this 
chapter we want to investigate the effect of nanoparticles on AP-1, NF-κB, and VEGF 
transcriptional activation, and to further determine the effect of angiogenesis in vivo 
using the CAM model. 
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MATERIALS AND METHODS 
 
 
Transient transfection and luciferase assay 
BEAS-2B cells were seeded in 12-well plates and cultured to 70% confluence.  
The cells were transiently transfected with AP-1, NF-κB, or VEGF reporter plasmids 
and pCMV-β-galactosidase (β-gal) using Lipofectamine (Invitrogen, Carlsbad, CA) 
according to the manufacturer’s instructions.  After transfection, the cells were 
cultured overnight, followed by different treatments.  Cells were washed in PBS and 
lysed with reporter lysis buffer (Promega, Madison, WI).  The luciferase (Luc) 
activities of the cell extracts were determined using the luciferase assay system 
(Promega, Madison, WI).  The relative luciferase activity (defined as VEGF reporter 
activity) was calculated as the ratio of Luc/β-gal activity, and normalized to the 
control. 
 
Chicken Chorioallantoic Membrane (CAM) angiogenesis assay 
 White Leghorn chicken eggs were fertilized and incubated at 37°C with 70% 
humidity for 9 days.  An artificial air sac was created over a region containing small 
blood vessels in the chicken chorioallantoic membrane (CAM) as described 
previously (Jiang et al., 2000).   To test angiogenesis, the BEAS-2B cells or A549 
cells were trypsinized, washed, and resuspended  at 10 x 107 cells/ml in serum-free 
medium containing 50% Matrigel (BD Biosciences, Bedford, MA).  Aliquots (3×106 
cells, 30 µl) of the mixture or the matrigel alone were then applied onto the CAM of 
9-day-old embryos.  The area around the implanted Matrigel was photographed 
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using a Nikon digital camera 4 days after the implantation, and the number of blood 
vessels was determined by counting the branching points of blood vessels in a unit 
area on the CAM.  The experiments were performed using 10 chicken embryos for 
each treatment.  Data were expressed as the mean ± SD from replicate experiments.  
 
Statistical Analysis 
The data were analyzed using SPSS statistics software package (SPSS, Chicago, 
IL).  All of the results are expressed as mean ± SD from three independent 
experiments, unless otherwise indicated, and the difference at p < 0.05 was considered 
significant.  
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RESULTS 
 
Low doses of WC-Co nanoparticles induced AP-1, NF-κB, and VEGF transcriptional 
activation   
BEAS-2B cells were co-transfected with AP-1, NF-κB, and VEGF reporter with 
β-gal plasmid, then treated with nano- or fine-size of WC-Co particles (WC/CO).  
As shown in Fig. 1, doses of 2.5 and 5 µg/cm2 nano-size WC/CO significantly 
induced AP-1, NF-κB, and VEGF transcriptional activation, while fine-size WC/CO 
had no effect.  These results shows that the nanoparticles induce AP-1, NF-κB, and 
VEGF transcriptional activation. 
 
The treatment of Beas-2B and A549 cells with low doses of WC-Co nanoparticles 
induced angiogenesis 
 In order to test the physiological function of WC-Co nanoparticles, Beas-2B 
cells were treated with the nanoparticles at 5 µg/cm2 for 24 h, or left untreated 
(control); cells were trypsinized, mixed with Matrigel, and used for angiogenesis 
assay in the CAM.  Beas-2B cells alone did not show an increase in angiogenesis, 
however, the nanoparticle treatment greatly induced angiogenesis (Fig. 2A).  The 
relative angiogenesis responses were analyzed by the number of microvessel branches 
in the unit area.  The nanoparticle treatment increased angiogenesis more than 5-fold 
compared to the control group (Fig. 2B).  To further test the effect of the 
nanoparticles in a different cell line, A549 cells were treated as above to analyze the 
angiogenesis response.  Although A549 cells induced angiogenesis, treatment with 
 51
nanoparticles greatly enhanced angiogenesis-nearly 5-fold induction of angiogenesis 
response was observed compared to that of A549 cells alone (Fig. 2C and D).  These 
data indicate that nanoparticles stimulate different cells to induce angiogenesis.  We 
also tested the effects of fine-sized particles in angiogenesis, and found that fine 
particles did not induce angiogenesis (data not shown).   
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Figures and Legends 
 
Fig.1. WC-Co nanoparticles induced AP-1, NF-κB, and VEGF transcriptional 
activation in Beas-2B cells. 
 
 
 
 
 
 
 
 
 
 
 
Fig.1. WC-Co nanoparticles induced AP-1, NF-κB, and VEGF transcriptional activation in 
Beas-2B cells.  (A) Beas-2B cells were co-transfected with AP-1 luciferase reporter plasmid 
(0.4 µg) and β-gal plasmid (0.2 µg).  After transfection, the cells were cultured overnight in 
fresh medium, then treated with nano- or fine-size WC-Co particles (WC/CO) (0, 2.5 and 5 
µg/cm2) for 24 h. The cells were then lysed and the supernatants were subjected to luc and 
β-gal activity assay.  Relative luciferase activity was determined by the ratio of luc to β-gal 
activity, and normalized to that of the control.  (B) Cells were co-transfected with NF-κB  
reporter plasmid (0.4 µg) and β-gal plasmid (0.2 µg), treated as above to analyze relative 
luciferase activity.  (C) Cells were co-transfected with human VEGF reporter plasmid (0.4 µg) 
and β-gal plasmid (0.2 µg), treated as above to analyze relative luciferase activity.   * 
indicates that the value was significantly different when compared to that of the control 
(P < 0.05).   
 
 
Fig.2. Beas-2B or A549 cells treated with WC-Co nanoparticles significantly induced 
angiogenesis.  
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Fig.2. Beas-2B or A549 cells treated with WC-Co nanoparticles significantly induced 
angiogenesis.  (A)  Beas-2B cells were treated without or with 5 µg/cm2 of WC-Co 
nanoparticles for 24 h, then trypsinized, resuspended in serum-free medium (3×107cells/ml, 
0.1 ml), and mixed in 1:1 ratio with Matrigel (Collaborative Biomedical Products, Bedford, MA).   
Aliquots of the mixture were then applied to the CAM of 9-day-old embryos.  After 96 h 
incubation, the area around the implanted Matrigel was photographed with a Nikon digital 
camera, and the numbers of blood vessel branching were counted.  Assays for each 
treatment were carried out using 10 embryos per experiment.  Representative photos were 
obtained from the CAM alone, the CAM with Beas-2B cells treated without or with WC-Co 
nanoparticles (upper panel), and magnified unit area of up panel (lower panel). Bar: 2 mm.  (B) 
The number of blood vessels was obtained by counting the branching of blood vessels, and 
the relative angiogenesis was obtained by normalizing to that of the CAM control.  The data 
represent the mean ±SE of the relative angiogenesis from 8 different embryos. ** indicates that 
the value was significantly different when compared to that of the control (P < 0.01).  (C) 
A549 cells were treated and used for the angiogenesis assay as described above for Beas-2B 
cells.  Representative photos generated from the CAM alone, or A549 cells treated without or 
with WC-Co nanoparticles.  (D) Relative angiogenesis was analyzed as above, and 
normalized to that of A549 cells alone. The mean ±SE of the relative angiogenesis was from 8 
different embryos. ** indicates that the value was significantly different when compared to that 
of A549 cells (P < 0.01).  
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DISCUSSION 
 
 
Transcription factors serve as integration points of the different signaling 
cascades that control the expression of a specific gene. The regulation of these 
transcription factors themselves is therefore of critical importance in determining the 
response to various physiological and environmental stimuli. To study the 
transcriptional activities of AP-1, NF-κB, and VEGF in WC-Co particles-treated cells, 
cells were treated with the same concentration of nano-sized or fine-sized particles, 
results showed that nanoparticles obviously induce the activity of the three 
transcriptional factors compared to fine-sized particles, although, we can also see 
subtle increase in activities of fine-sized particles, which may indicate that heavy 
metals can upregulate transcriptional activities of AP-1, NF-κB, and VEGF regardless 
of powder size. VEGF shows the biggest activation difference between fine-sized and 
nano-sized particles when compared to AP-1 and NF-κB, insofar. VEGF is among the 
most powerful angiogenic cytokines in many cancers
24
, thus, we hypothesized that 
VEGF is also the most important factor in WC-Co nanoparticle- induced tumor 
growth and angiogenesis compared to AP-1 and NF-κB. 
Angiogenesis assay in chicken embryo (CAM) was used as in vivo assay to 
study the effects of WC-Co nanoparticle. CAM assay possesses several advantages, 
among the most valuable features, it is relatively easy to carry out and less expensive 
than other in vivo angiogenesis assays, however, some articles pointed out that the 
CAM itself already contains a well-developed vascular network, during the course of 
embryonic development. CAM undergoes gradual change in endothelial cell 
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proliferation, which makes it difficult to discriminate between newly formed 
capillaries and the already existing ones
25,26
. In order to reduce the unrelated factors 
that would influence our results, we perform ten replicates for each treatment. The 
results show that nanoparticle-treated cells are more efficient in inducing angiogenesis 
in vivo in xenografts from both A549 cell line and BEAS-2B cell line (with almost the 
same activation pattern). This suggests that WC-Co nanoparticle-treated lung 
epithelial cells have significantly increased capacity to induce angiogenesis in vivo.  
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Discussion 
 
WC-Co nanoparticles 
Despite the extensive studies on WC-Co toxicity, there is still much left to be 
explored regarding its mechanism of action as well as intracellular damage. With the 
nanotechnology industry growing exponentially over these few years, the evolution of 
nanotechnology brings yet another aspect of WC-Co—the biological toxicity of 
WC-Co nanoparticles. Because of the extremely small physical size of the 
nanoparticles, which is similar to many biological molecules and structures, like 
antibodies, proteins, viruses, etc.  they can easily enter cells, organelles, tissues and 
interact with functional biomolecular structures (e.g. DNA, RNA)
1
. There is a 
common assumption that the nanoscale materials act via quite different mechanisms 
and reactions compared to their fine sized counterparts. Recent evidence has indicated 
that nanoparticles exhibit a higher deposition in all regions of the respiratory tract 
when compared to the fine particles
2
. 
Nanoparticles and reactive oxygen species in the cells 
Recent studies indicated that the adverse and toxic effects of inhaled 
nanoparticles may be associated with the oxidative stress by the increasing generation 
of reactive oxygen species (ROS)
3,4,5
. ROS include superoxide, hydrogen peroxide 
(H2O2) and hydroxyl radical. Low levels of ROS are produced by all aerobic 
organisms through the oxygen reduction process. ROS are also induced by growth 
factors and cytokines and are important for cancer cell proliferation and tumor 
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development. In fact, in recent years, ROS have been regarded as having carcinogenic 
potential and have been associated with tumor progression in various studies. ROS 
possess four properties that contribute to carcinogenesis: 1) they cause structural 
change in DNA by introducing base-pair mutation, deletion, insertion, rearrangement, 
and sequence amplification. 2) they initiate lipid peroxidation. 3) they activate 
cytoplasmic and nuclear signal transduction pathways. 4) they can modulate the 
activity of stress protein and stress genes so as to regulate growth, differentiation, and 
cell death. Cells have developed a variety of enzymatic and non-enzymatic 
mechanisms to defend themselves against damage resulting from oxidative stress 
including antioxidant defense such as glutathione and antioxidant enzymes. The most 
important antioxidant enzymes include the superoxide dismutases (SOD
-1
 and SOD
-2
), 
which catalyze O2·− to H2O2 + H2O; catalase, which catalyzes H2O2 to O2 + H2O; and 
glutathione peroxidase which converts H2O2 to H2O.  Recent studies indicated that 
expression of NADPH oxidase may play an important role in ROS generation in some 
cancer cells
6,7,8
. 
 
PI3K, AKT, and ERK1/2 regulate VEGF and HIF-1 expression
 
Hypoxia-inducible factor 1 (HIF-1), is a heterodimeric transcription factor 
composed of two subunits: HIF-1α and HIF-1β. HIF-1α is degraded during normoxia, 
whereas HIF-1β is constitutively expressed and stable under normoxic conditions. In 
contrast, HIF-1α is rapidly ubiquitinated by the von Hippel-Lindau tumor suppressor 
E3 ligase complex and subjected to proteasomal degradation.  During hypoxia, 
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HIF-1α proteosomal degradation is prevented through HIF-1α protein modifications, 
leading to its accumulation and translocation to the nucleus to form an active 
heterodimer with HIF-1β9. It has been found that HIF-1α protein synthesis can also be 
regulated by activation of the phosphatidylinositol 3-kinase (PI3K) and ERK 
mitogen-activated protein kinase (MAPK) pathway
10
. Various studies demonstrated 
that the expression of HIF-1α is induced in human cells by hypoxia, growth factors, 
and oncogenes. HIF-1α protein content is a rate-limiting factor for HIF-1 activity. 
HIF-1 regulates the expression of many genes, including VEGF, heme oxygenase 1, 
inducible nitric oxide synthase (iNOS), several glycolytic enzymes, p21 and others
11
. 
HIF-1 activation is important for tumorigenicity and angiogenesis in nude mice. 
HIF-1α expression is frequently increased in many human cancers and in 
angiogenesis
12,13 
It has been demonstrated that PI3K/AKT signaling pathway is required for 
HIF-1-mediated VEGF expression in response to growth factor stimulation and 
oncogene activation
14
. The activation of PI3K or AKT alone is sufficient to increase 
VEGF expression and that PI3K signaling is required for growth factor-induced 
VEGF expression in endothelial cells
15
. VEGF expression is also induced by growth 
factors and oncogenes such as Ras through the activation of MAP kinases including 
ERK1/2, which regulate growth factor-induced cell growth and tumor growth
16
. 
VEGF transcriptional activation is mainly regulated by HIF-1 in response to hypoxia 
and growth factors, and HIF-1 expression is in turn regulated by the activation of 
ERK1/2 in response to growth factor stimulation and hypoxia
17,18
 Thus, PI3K, AKT, 
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and ERK1/2 can cooperate to play an important role in regulating HIF-1 and VEGF 
expression in response to growth factors and hypoxia. However, the role of VEGF in 
ROS signaling is still elusive, and the relationship between the ROS and VEGF 
remains to be elucidated. Our goal was to investigate if PI3K, AKT, and ERK1/2 are 
downstream of ROS signaling in inducing VEGF expression. Although we do not 
understand completely the highly complex nature of the relationship between these 
pathways, we have obtained sufficient preliminary data to study defined components 
in these signaling pathways, and to elucidate the potential molecular mechanisms of 
PI3K, AKT, and ERK1/2 in ROS-mediated VEGF expression. 
 
VEGF and Angiogenesis 
Tumor growth and metastasis were proposed to be angiogenesis-dependent in 
1971
19
. Angiogenesis is the process by which new blood capillaries are generated 
from the pre-existing vasculature. The process involves multiple steps including 
dissolution of the basement membrane of the vessel, endothelial cell proliferation and 
migration, formation of a new vessel lumen and vessel branches, as well as maturation 
of the new vessel by the recruitment of pericytes and the formation of basement 
membrane
20
. 
21
. 
Recent studies have indicated that the VEGF and VEGF receptor signaling 
system and the angiopoietin/Tie2 signaling system are central regulators of embryonic 
angiogenesis
22
. VEGF and its receptors are the major regulators of the phase of vessel 
morphogenesis in angiogenesis, while Ang-1 and its receptor, Tie-2, are implicated in 
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the vascular maturation phase
23
. VEGF expression is regulated by tissue oxygen 
content and by growth factors and cytokines, including platelet-derived growth factor, 
epidermal growth factor, insulin, insulin-like growth factor-I, and tumor necrosis 
factor α. VEGF transcription is regulated by many transcription factors including 
AP-1, NF-κB and HIF-1α. Hypoxia is the major physiological stimulus for VEGF 
expression. Hypoxia stimulates VEGF expression through gene transcription, mRNA 
stabilization and translational regulation. The transcriptional regulation of VEGF is 
mediated by HIF-1, which regulates both hypoxia- and growth factor-induced VEGF 
expression in tumor cells
24
. 
 
Roles of PI3K, AKT, ERK1/2, AP-1 and NF-κB in angiogenesis  
 PI3K are heterodimers comprised of a 110-kDa catalytic subunit and an 85-kDa 
regulatory subunit
25
. PI3K catalyzes the phosphorylation of 
phosphatidylinositol-containing lipids at their 3-end position. Receptor tyrosine 
kinases activate PI3K, and this activation has been implicated in several human 
cancers. Several cellular functions such as proliferation, differentiation, anti-apoptosis, 
tumorigenesis and angiogenesis have been linked to PI3K activity. An important 
downstream target of PI3K is the serine-threonine kinase AKT. PI3K catalyzes the 
production of PtdIns-3,4-P2 and PtdIns-3,4,5-P3  to help recruiting AKT and PDK1 to the 
membrane
26272829
. The role of PI3K in angiogenesis, an important process involved in 
neovascularization, has already been established
30
. The activated receptor tyrosine 
kinases increase HIF-1α protein synthesis via PI3K/AKT pathway and MEK/ERK 
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pathway
31
. Activation of oncogene Ras and the activation of PI3K pathway stimulate 
the expression and secretion of VEGF in tumor cells.  PI3K/AKT pathway regulates 
the expression of VEGF via HIF-1α independently of oxygen concentration in 
cells
32,33
 
  It was initially observed that p85, the regulatory subunit of PI3K, is 
constitutively associated with and phosphorylated by Flk-1/KDR, resulting in 
increased PI3K and AKT activities in vitro. Also, VEGF-induced endothelial cell 
survival was blocked by wortmannin and LY294002, pharmacological inhibitors of 
PI3K, and by overexpression of a dominant-negative form of AKT. The direct roles of 
PI3K and AKT in regulating angiogenesis was obtained by the forced expression of 
PI3K or AKT by the avian retroviral vector RCAS in the CAM, and it is found that 
the forced expression of active forms of PI3K or AKT by RCAS vector greatly 
increased the number of the sprouting vessels and size of the vessels to induce 
angiogenesis in vivo, suggesting that PI3K or AKT activation is sufficient for 
inducing angiogenesis
34
.  
Mitogen-activated protein kinases (MAPKs) compose a family of protein 
kinases that are activated by extracellular stimuli to phosphorylate specific serines and 
threonines on protein substrates.  Among these, ERK1 and ERK2 are widely 
expressed and are involved in cell proliferation and tumor growth induced by 
carcinogens.  The activation of ERK1/2 was important for regulating angiogenesis 
induced by growth factors and integrin.  AP-1 and NF-κB are downstream of 
ERK1/2 signaling.  AP-1 and NF-κB were also implicated in regulating angiogenesis 
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and inflammation. However, there is a lack of direct evidence to link ROS, PI3K, 
AKT, ERK1/2, AP-1, NF-κB and angiogenesis.  
 
WC-Co nanoparticles and its potential regulatory mechanisms 
WC-Co is widely used as cemented carbide hard metal in a wide range of 
products in aerospace, automobiles, and home appliances. In contrast to hard metals, 
conventional materials have hardness and toughness that are mutually exclusive. 
WC-Co nanoparticles have many advantages over fine particles including the greatly 
improved toughness, hardness, and wear resistance. Occupational exposure to WC-Co 
has been associated with an increased risk of lung diseases including lung cancer.  
Previous studies showed that WC-Co treatment induces micronuclei formation in rat 
lung
35
. During various processes, workers are exposed to various particle sizes of 
WC-Co heavy metal including nanoparticles. Recent evidence indicates that 
nanoparticles exhibit a higher deposition in all regions of the respiratory tract when 
compared to the fine particles, and that exposure to nanoparticles may induce 
cytotoxicity, pulmonary inflammation, and/or other adverse effects in the cells and 
lung
36
. However, the molecular mechanisms by which WC-Co exposure causes lung 
injury and carcinogenesis remain to be clarified.  In this study, we found that WC-Co 
nanoparticles increase ROS production in the cells, which induces other cellular 
signaling molecules such as AKT and ERK1/2 activation.   AP-1 and NF-κB are 
important transcription factors involved in lung injury and inflammation, VEGF is a 
potent angiogenic inducer.   
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We found that low doses of WC-Co nanoparticles increased the transcriptional 
activation of AP-1, NF-κB, and VEGF.  These results are consistent with the 
nanoparticle effect in increasing oxidative stress and generation of ROS.  ROS are 
produced by all aerobic organisms through the oxygen reduction process and can be 
induced by growth factors and cytokines. Our results showed that nanoparticles, but 
not fine particles of WC-Co at 5 µg/cm2, stimulated ROS production. As we expected, 
catalase inhibited ROS production, indicating that H2O2 is one of the species of ROS 
induced by nano-size WC-Co. Growing evidence has showed that H2O2 may act as a 
second messenger to regulate various cellular functions and signaling pathways 
including ERK, phosphatidylinositol 3-kinase (PI3K), small GTPases, NF-κB, and 
nitrogen oxide(NO) pathways
37
, Recent reports show that PI3K and ERK may 
regulate ROS production
38,39
. We found that the inhibitors of PI3K and ERK1/2, 
LY294002 and U0126, did not affect ROS generation. In contrast, treatment with 
catalase inhibited both AKT and ERK1/2 activation. These results suggest that ROS 
act as upstream inducers of AKT and ERK activity in the cells. This is consistent with 
previous studies in a different cell system that showed H2O2 being upstream of AKT 
and ERK. We further show that WC-Co nanoparticles strongly induce AP-1, NF-κB, 
and VEGF transcriptional activation. Angiogenesis is critical in the injury repair, 
inflammation, tumor development, and neovascularization
40
. We further show that 
treatment of BEAS-2B cells with nano-sized WC-Co at low doses induced 
angiogenesis, while equal doses of fine-sized WC-Co did not have a strong effect on 
angiogenesis (data not shown). Similar results were obtained using A549 cells, 
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indicating the general ability of nanoparticles to induce angiogenesis.  These results 
are consistent with the induction of transcriptional activation of AP-1, NF-κB, and 
VEGF in this study.   
Our studies elucidated cellular effects of WC-Co nanoparticles and potential 
molecular mechanisms involved in response to WC-Co nanoparticle exposure. 
However, in vivo systems are extremely complicated, the inhaled nanoparticles could 
react with biological components, and lead to unique biodistribution, clearance, 
immune response, and metabolism. It is difficult to predict the movements and 
location of nanoparticles after in vivo exposure in a complex system of an organism. 
Consequently, more studies in  in vivo systems are required.  We demonstrate that 
WC-Co nanoparticles increase ROS formation, and that activated PI3K/AKT and 
MEK/ERK pathways act as the downstream mediators of ROS. We also show that 
WC-Co nanoparticles promote AP-1, NF-κB, and VEGF transcriptional activation. It 
is temping to propose the following signaling cascade: WC-Co nanoparticles induce 
ROS generation leading to AKT and ERK activation, which in turn activates AP-1, 
NF-κB and VEGF transcription. Thus, an important future direction is to test whether 
transcriptional activation of AP-1, NF-κB, and VEGF is mediated through ROS 
production, AKT and ERK. 
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Conclusion 
 
In conclusion, our studies provide a fundamental understanding of the effects of 
WC-Co nanoparticles in the lung epithelial cells and in CAM angiogenesis model. We 
have identified crucial roles of ROS and other signaling molecules (PI3K/AKT, 
MEK/ERK, AP-1, NF-κB, and VEGF) in regulating angiogenesis induced by WC-Co 
nanoparticles. Occupational Safety and Health Administration (OSHA) has 
specifically noted the need for mechanistic information in order to assess the risk of 
the nanoparticles. After we learn about the essential biological responses and the 
underlying mechanisms of nanoparticle toxicity, we can begin to develop 
mechanism-based interventions, such as specific antioxidant therapies and novel 
chemical approaches to decrease the proangiogenic toxicity of WC-Co nanoparticles 
and other nanoparticles. 
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